Methylprednisolone Withdrawn Phase 2 Trials for Graft Versus Host Disease, Acute / Intestinal Graft Versus Host Disease Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02425813Methylprednisolone Sodium Succinate in Treating Patients With Acute Graft-versus-Host Disease of the Gastrointestinal Tract